首页 | 本学科首页   官方微博 | 高级检索  
     


Safety of sublingual immunotherapy Timothy grass tablet in subjects with allergic rhinitis with or without conjunctivitis and history of asthma
Authors:J. Maloney  S. Durham  D. Skoner  R. Dahl  A. Bufe  D. Bernstein  K. Murphy  S. Waserman  G. Berman  M. White  A. Kaur  H. Nolte
Affiliation:1. Merck & Co., Inc., Whitehouse Station, NJ, USA;2. Royal Brompton and Harefield Hospitals National Health Service Trust and Imperial College, London, UK;3. Allegheny General Hospital, Pittsburgh, PA, USA;4. Temple University School of Medicine, Philadelphia, PA, USA;5. Allergy Centre, Odense University Hospital, Odense, Denmark;6. Experimental Pneumonology, Ruhr‐University Bochum, Bochum, Germany;7. Bernstein Clinical Research Center, Cincinnati, OH, USA;8. Boys Town National Research Hospital, Boys Town, NE, USA;9. McMaster University, Hamilton, ON, Canada;10. Allergy & Asthma Specialists, Minneapolis, MN, USA;11. Institute for Asthma & Allergy, Wheaton, MD, USA
Abstract:
Keywords:allergic rhinitis  asthma  grass  safety  sublingual immunotherapy
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号